TransMedics Group, Inc.
TMDX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001756262
In the last 90 days, TransMedics Group, Inc. insiders filed 1 open-market purchase and 1 sale; 385 institutions reported holding it in 13F filings for Q3 2026, worth $3.02B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:58 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 27, 2025 | Feb 26, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Revenue | $605.5M | $441.5M | $241.6M | $93.5M | $30.3M |
| Cost of revenue | $242.7M | $179.5M | $87.5M | $28.2M | $9.10M |
| Gross profit | $362.8M | $262.1M | $154.1M | $65.3M | $21.2M |
| Operating expenses | $254.2M | $224.6M | $182.8M | $96.7M | $60.6M |
| Research and development | $69.1M | $56.0M | $36.1M | $26.8M | $22.3M |
| Selling, general and administrative | $185.2M | $168.6M | $119.6M | $69.9M | $38.3M |
| Operating income | $108.6M | $37.5M | -$28.7M | -$31.4M | -$39.4M |
| Interest expense | – | – | $10.8M | $3.73M | $3.87M |
| Income tax | -$82.8M | $316.0K | -$1.70M | – | – |
| Net income | $190.3M | $35.5M | -$25.0M | -$36.2M | -$44.2M |
| EPS, basic | $5.60 | $1.07 | $-0.77 | $-1.23 | $-1.60 |
| EPS, diluted | $4.87 | $1.01 | $-0.77 | $-1.23 | $-1.60 |
| Weighted shares, basic | 34.0M | 33.2M | 32.5M | 29.6M | 27.6M |
| Weighted shares, diluted | 40.5M | 35.2M | 32.5M | 29.6M | 27.6M |
| Margins and growth | |||||
| Gross margin | 59.9% | 59.4% | 63.8% | 69.8% | 69.9% |
| Operating margin | 17.9% | 8.5% | -11.9% | -33.6% | -130.3% |
| Net margin | 31.4% | 8.0% | -10.4% | -38.8% | -146.1% |
| Revenue growth, year over year | +37.1% | +82.7% | +158.5% | +208.8% | +18.0% |
| Net income growth, year over year | +436.6% | – | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 27, 2025 | Feb 26, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Cash and equivalents | $488.4M | $336.6M | $394.8M | $201.2M | $25.6M |
| Short-term investments | – | – | – | – | $66.9M |
| Accounts receivable | $84.3M | $97.7M | $63.6M | $27.6M | $5.93M |
| Inventory | $48.9M | $46.6M | $44.2M | $20.6M | $14.9M |
| Total current assets | $637.8M | $497.2M | $510.7M | $252.3M | $118.7M |
| Property, plant and equipment | $327.7M | $286.0M | $173.9M | $19.2M | $9.84M |
| Goodwill | $11.5M | $11.5M | $12.0M | – | – |
| Intangible assets | $1.95M | $2.15M | $2.35M | – | – |
| Total assets | $1.07B | $804.1M | $706.0M | $277.1M | $134.9M |
| Accounts payable | $10.3M | $10.3M | $12.7M | $3.34M | $6.65M |
| Short-term debt | $10.0M | – | – | – | – |
| Total current liabilities | $89.3M | $59.9M | $54.9M | $23.7M | $23.2M |
| Long-term debt | – | – | – | $58.7M | $35.2M |
| Total liabilities | $595.3M | $575.5M | $568.8M | $89.8M | $67.0M |
| Shareholders' equity | $473.1M | $228.6M | $137.2M | $187.4M | $67.9M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 24, 2026 | Feb 27, 2025 | Feb 26, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Operating cash flow | $192.8M | $48.8M | -$13.0M | -$45.8M | -$28.9M |
| Capital expenditures | $59.3M | $129.7M | $151.8M | $11.9M | $3.52M |
| Free cash flow | $133.6M | -$80.9M | -$164.9M | -$57.7M | -$32.4M |
| Depreciation and amortization | $27.2M | $19.8M | $8.18M | $3.48M | $1.82M |
| Stock-based compensation | $36.9M | $33.2M | $19.8M | $10.3M | $6.88M |
| Investing cash flow | -$59.3M | -$129.3M | -$194.0M | $54.5M | $29.3M |
| Financing cash flow | $16.9M | $22.9M | $400.4M | $167.9M | $1.39M |
| Net change in cash | $151.7M | -$58.2M | $193.6M | $175.6M | $999.0K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 6.1% | 7.5% | 8.2% | 11.0% | 22.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 34.7M | +1.6% | SEC |
| Jul 30, 2026 | 34.7M | +1.7% | SEC |
| Apr 30, 2026 | 34.6M | +2.1% | SEC |
| Jan 30, 2026 | 34.3M | +1.9% | SEC |
| Oct 17, 2025 | 34.2M | +1.8% | SEC |
| Jul 25, 2025 | 34.1M | +2.2% | SEC |
| Apr 30, 2025 | 33.8M | +2.7% | SEC |
| Jan 31, 2025 | 33.7M | +2.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.